Page last updated: 2024-08-22

tiletamine hydrochloride and interleukin-8

tiletamine hydrochloride has been researched along with interleukin-8 in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's7 (87.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bando, H; Matsumoto, G; Muta, M; Nakamura, T; Namekawa, J; Tohyama, K; Toi, M; Umezawa, K1
Flynn, BL; Masters, KS1
Caggia, S; Cardile, V; Frasca, G; Libra, M; Malaponte, G; Panico, A; Umezawa, K1
Bevelacqua, Y; Caggia, S; Cardile, V; Coco, M; Frasca, G; Libra, M; Malaponte, G; Mazzarino, MC; Stivala, F; Umezawa, K1
Fukai, M; Funakoshi, T; Goto, R; Ichihara, S; Ichikawa, N; Katsurada, T; Kobayashi, N; Oura, T; Ozaki, M; Suzuki, T; Todo, S; Umezawa, K; Yamashita, K1
Aiura, K; Itano, O; Kitagawa, Y; Matsuda, S; Suzuki, K; Takeuchi, O; Umezawa, K1
Aoki, D; Fujii, T; Iwata, T; Kawakami, Y; Kawamura, N; Kobayashi, A; Nishio, H; Park, J; Sugiyama, J; Sumimoto, H; Susumu, N; Umezawa, K; Yaguchi, T1
Fukuda, K; Fukushima, A; Hirakata, A; Inokawa, S; Keino, H; Okada, AA; Sato, Y; Umezawa, K; Watanabe, T1

Other Studies

8 other study(ies) available for tiletamine hydrochloride and interleukin-8

ArticleYear
Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2005, Feb-01, Volume: 11, Issue:3

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzamides; Breast Neoplasms; Cell Line, Tumor; Cyclohexanones; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Interleukin-6; Interleukin-8; Lymphotoxin-alpha; Male; Mice; Mice, Inbred BALB C; Mice, SCID; NF-kappa B; Phosphorylation; Signal Transduction; Time Factors; Tumor Necrosis Factor-alpha; Xenograft Model Antitumor Assays

2005
An efficient synthesis of (+/-)-frondosin B using a Stille-Heck reaction sequence.
    Organic & biomolecular chemistry, 2010, Mar-21, Volume: 8, Issue:6

    Topics: Cyclohexanones; Heterocyclic Compounds, 4 or More Rings; Interleukin-8; Mesylates; Stereoisomerism

2010
Dehydroxymethylepoxyquinomicin inhibits expression and production of inflammatory mediators in interleukin-1beta-induced human chondrocytes.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2010, Volume: 25, Issue:4-5

    Topics: Benzamides; Cartilage, Articular; Cells, Cultured; Chemokine CCL2; Chemokine CCL5; Chondrocytes; Cyclohexanones; Cyclooxygenase 2; Humans; Inflammation Mediators; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-8; Nitrates; Nitric Oxide Synthase Type II

2010
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, prevents inflammatory injury induced by interferon-gamma and histamine in NCTC 2544 keratinocytes.
    Clinical and experimental pharmacology & physiology, 2010, Volume: 37, Issue:7

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Cell Line; Chemokine CCL2; Chemokine CCL5; Cyclohexanones; Histamine; Humans; Hydrocortisone; Inflammation; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-8; Keratinocytes; NF-kappa B

2010
A novel NF-κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates inflammatory colonic injury in mice.
    Journal of Crohn's & colitis, 2012, Volume: 6, Issue:2

    Topics: Animals; Benzamides; CD4-Positive T-Lymphocytes; Chemokine CCL2; Colitis; Cyclohexanones; Cytokines; Dextran Sulfate; HT29 Cells; Humans; Interleukin-12 Subunit p40; Interleukin-17; Interleukin-1beta; Interleukin-6; Interleukin-8; Macrophages; Male; Mice; Mice, Inbred C57BL; NF-kappa B; RNA, Messenger; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha

2012
Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
    Clinical & experimental metastasis, 2013, Volume: 30, Issue:4

    Topics: Adenocarcinoma; Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Benzamides; Blotting, Western; Cell Movement; Cell Proliferation; Cyclohexanones; Deoxycytidine; Disease Models, Animal; Fluorescent Antibody Technique; Gemcitabine; Humans; Immunoenzyme Techniques; Interleukin-8; Liver Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Cells, Cultured

2013
Immunosuppression through constitutively activated NF-κB signalling in human ovarian cancer and its reversal by an NF-κB inhibitor.
    British journal of cancer, 2014, Jun-10, Volume: 110, Issue:12

    Topics: Adoptive Transfer; Animals; Arginase; Benzamides; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Culture Media, Conditioned; Cyclohexanones; Dendritic Cells; Female; Humans; Immune Tolerance; Interleukin-6; Interleukin-8; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Signal Transduction; Transcription Factor RelA; Transplantation, Heterologous

2014
Dehydroxymethylepoxyquinomicin, a novel nuclear factor-κB inhibitor, reduces chemokines and adhesion molecule expression induced by IL-1β in human corneal fibroblasts.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2015, Volume: 253, Issue:4

    Topics: Benzamides; Cell Proliferation; Cell Survival; Cells, Cultured; Chemokine CCL2; Corneal Keratocytes; Cyclohexanones; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Humans; Intercellular Adhesion Molecule-1; Interleukin-1beta; Interleukin-8; NF-kappa B; Transcription Factor RelA

2015